sever
acut
respiratori
syndrom
highli
infecti
upper
respiratori
tract
diseas
caus
sarscov
previous
unidentifi
human
coronaviru
pro
viral
cystein
proteas
critic
pathogen
life
cycl
henc
therapeut
target
import
recent
elucid
crystal
structur
enzym
provid
opportun
discoveri
inhibitor
ration
drug
design
current
studi
gold
dock
program
util
conduct
extens
dock
studi
target
crystal
structur
develop
robust
predict
dock
protocol
valid
dock
protocol
use
conduct
structurebas
virtual
screen
asinex
platinum
collect
biolog
evalu
screen
select
compound
carri
identifi
novel
inhibitor
viral
proteas
sever
acut
respiratori
syndrom
sar
highli
infecti
upper
respiratori
tract
diseas
reach
epidem
statu
first
report
outbreak
diseas
occur
guangdong
provinc
china
within
span
year
diseas
spread
countri
asia
north
america
europ
diseas
infect
nearli
peopl
worldwid
averag
mortal
rate
around
etiolog
agent
diseas
identifi
previous
unknown
human
coronaviru
christen
sar
coronaviru
sarscov
envelop
posit
sens
rna
viru
coronavirida
famili
contain
singl
chain
rna
genom
nucleotid
largest
viral
rna
genom
report
date
although
report
occurr
sar
infect
sinc
diseas
still
treat
high
health
risk
high
virul
contagi
natur
histor
evid
sever
viral
diseas
influenza
suggest
recurr
epidem
outbreak
caus
wildtyp
mutat
variant
viru
common
recurr
usual
spread
long
period
time
may
occur
region
geograph
distant
therefor
urgent
need
understand
etiolog
patholog
possibl
therapeut
target
viru
knowledg
gain
studi
use
design
therapi
current
form
viru
may
carri
futur
mutat
variant
pathogen
virus
famili
sarscov
genom
contain
two
open
read
frame
connect
ribosom
frame
shift
encod
two
larg
replicas
polyprotein
kda
kda
function
viral
replic
transcript
process
polyprotein
process
viral
proteas
gener
function
compon
multiprotein
complex
known
viral
replicasetranscriptas
coronavirus
util
three
proteas
proteolyt
process
sarscov
known
encod
two
proteas
purpos
two
proteas
includ
papainlik
cystein
proteas
pro
chymotrypsinlik
cystein
proteas
known
proteas
pro
pro
enzym
also
call
main
proteas
pro
sinc
play
pivot
role
process
viral
polyprotein
control
replicas
complex
activ
enzym
indispens
viral
replic
infect
process
therebi
make
ideal
target
design
antivir
therapi
avail
multipl
crystal
structur
enzym
cocrystal
ligand
make
target
amen
structurebas
drug
design
protein
crystallographi
well
biomolecular
nmr
play
major
role
drug
discoveri
effort
enzym
first
crystal
structur
pro
dimer
peptid
cmk
inhibitor
elucid
sinc
twenti
crystal
structur
enzym
elucid
crystal
structur
includ
enzym
apo
form
well
peptid
small
molecul
inhibitor
bound
enzym
activ
site
crystal
structur
also
help
elucid
ph
depend
conform
chang
activ
site
enzym
inducedfit
effect
ligand
bind
well
mechan
irrevers
inactiv
specif
class
peptid
inhibitor
current
drug
design
effort
enzym
broadli
classifi
two
categori
peptid
small
molecul
base
inhibitor
figur
show
latest
peptid
small
molecul
base
inhibitor
devis
use
structur
inform
substrat
specif
profil
pro
enzym
peptid
inhibitor
design
attach
reactiv
warhead
type
agent
peptid
mimick
natur
substrat
warhead
group
includ
michael
acceptor
aldehyd
epoxi
keton
halo
methyl
keton
other
inhibitor
act
twostep
procedur
wherein
first
bind
form
noncoval
complex
enzym
warhead
group
locat
close
vicin
catalyt
residu
follow
nucleophil
attack
catalyt
cystein
coval
adduct
format
categori
includ
nonpeptid
inhibitor
contain
small
molecul
scaffold
inhibitor
discov
use
variou
techniqu
structur
base
virtual
screen
pharmacophor
base
screen
well
high
screen
methodolog
part
effort
discov
small
molecul
base
inhibitor
pro
conduct
structurebas
virtual
screen
pro
enzym
structur
base
virtual
screen
involv
silico
evalu
databas
molecul
experiment
determin
structur
compar
model
protein
target
use
dock
program
evalu
gener
dock
pose
carri
use
metric
score
function
identifi
put
binder
compar
high
throughput
screen
entir
compound
librari
small
set
molecul
select
basi
screen
strategi
evalu
biolog
assay
identifi
inhibitor
target
present
studi
asinex
platinum
collect
screen
pro
enzym
crystal
structur
use
gold
dock
program
biolog
evalu
select
set
compound
pro
inhibit
assay
led
identif
novel
hit
activ
low
micromolar
rang
could
optim
develop
potent
antivir
therapi
sarscov
infect
analysi
pro
bind
site
requir
kda
pro
enzym
function
homodim
show
three
structur
domain
antiparallel
bbarrelshap
structur
akin
serin
proteas
chymotrypsin
activ
site
locat
groov
domain
ii
fairli
solvent
expos
shallow
caviti
enzym
atyp
cystein
proteas
contain
catalyt
diad
instead
triad
multipl
crystal
structur
pro
cocrystal
inhibitor
cocrystal
peptid
michaelacceptor
base
inhibitor
pro
structur
pdb
code
structur
analog
cbz
protect
hexapeptidecmk
chloro
methyl
keton
inhibitor
pdb
code
undergo
similar
bind
site
interact
therefor
cocrystal
pose
fig
b
use
describ
relev
bind
site
interact
enzym
subsit
specif
mutat
studi
carri
substrat
relat
coronaviru
proteas
understand
specif
bind
subsit
effect
mutat
substrat
bind
catalyt
effici
enzym
found
mutat
posit
produc
signific
loss
enzym
activ
correspond
sub
site
specif
glutamin
residu
subsit
interest
prefer
substrat
amino
acid
side
chain
site
alanineserin
leucin
valineserin
case
cocrystal
pose
bcarbon
michael
acceptor
form
coval
bond
sulfur
catalyt
cystein
cycliz
ketoglutamin
group
occupi
subsit
act
entrop
favor
surrog
glutamin
side
chain
nativ
substrat
carbonyl
oxygen
ketoglutamin
group
undergo
hydrogen
bond
interact
ring
amid
nh
form
hydrogen
bond
donor
interact
backbon
carbonyl
oxygen
side
chain
also
close
vicin
form
hydrogen
bond
interact
ring
amid
nh
group
minor
rotamer
adjust
interact
natur
nitrogen
side
chain
surrog
side
chain
carboxyl
oxygen
seen
crystal
structur
pro
inhibit
aza
peptid
epoxid
pdb
code
well
peptid
aldehyd
pdb
code
base
inhibitor
met
subsit
primarili
hydrophob
natur
occupi
leucin
valin
residu
respect
termin
ethyl
group
ligand
occupi
site
undergo
hydrophob
interact
addit
hydrogen
bond
notic
peptid
backbon
ligand
residu
overal
presenc
hydrophob
group
site
hydrogen
bond
acceptor
site
consid
critic
pharmacophor
requir
fig
bind
put
inhibitor
studi
initi
one
crystal
structur
pdb
code
pro
coval
bound
cbz
protect
hexapeptidecmk
inhibitor
avail
ligand
larg
number
rotat
bond
improperli
resolv
coordin
termi
nal
portion
ligand
catalyt
cystein
sulfur
form
coval
adduct
ligand
therefor
feasibl
conduct
pose
valid
studi
use
ligand
structur
seri
phthalhydrazid
base
peptid
analogu
supplementari
inform
fig
inhibitori
activ
pro
report
util
valid
studi
use
gold
select
bind
site
definit
score
function
util
bind
pose
calcul
amongst
thirteen
ketoglutamin
base
analogu
four
ic
valu
lm
less
pic
p
ic
lm
four
ic
valu
rang
lm
five
activ
greater
lm
pic
ic
p
lm
typic
molecul
higher
bind
affin
would
better
interact
geometr
profil
compar
molecul
weaker
bind
affin
score
function
abl
evalu
qualiti
bind
pose
separ
pose
activ
ic
lm
inact
ic
p
lm
base
dock
score
dock
calcul
conduct
use
gold
standard
mode
speed
allow
genet
oper
per
dock
pose
goldscor
function
evalu
predict
abil
found
provid
score
base
separ
activ
inact
supplementari
inform
tabl
separ
becom
pronounc
one
outlier
molecul
award
lower
dock
score
discount
comparison
valid
protocol
util
actual
screen
dock
larg
virtual
screen
databas
comput
expens
exercis
level
calcul
util
dock
process
critic
factor
govern
comput
time
requir
screen
process
one
approach
success
use
previous
toward
minim
overal
time
without
compromis
qualiti
carri
multistag
cascad
dock
involv
less
intens
faster
dock
protocol
earli
stage
screen
gradual
increment
comput
complex
proceed
toward
final
stage
typic
earli
stage
screen
aim
look
shape
complementar
dock
molecul
bind
site
elimin
molecul
low
probabl
attain
proper
bind
pose
within
activ
site
contrari
final
stage
screen
process
involv
select
deserv
hit
base
complementar
bind
site
interact
geometr
qualiti
bind
pose
elimin
stage
handl
less
intens
dock
calcul
rigor
protocol
incorpor
exhaust
conform
sampl
critic
requir
final
stage
screen
case
three
stage
dock
protocol
increas
comput
complex
fig
implement
use
gold
dock
program
choic
virtual
screen
databas
play
major
role
term
area
synthet
chemic
space
cover
search
novelti
scaffold
identifi
screen
feasibl
synthet
modif
identifi
hit
asinex
platinum
collect
use
studi
druglik
collect
compound
contain
scaffold
uniqu
databas
furthermor
around
compound
databas
point
divers
provid
enhanc
opportun
synthet
tractabl
modif
explor
structureact
relationship
addit
asinex
platinum
compound
databas
synthes
inhous
make
resuppli
short
notic
allow
better
qualiti
control
suppli
product
prefiltr
stage
virtual
screen
initi
databas
compris
molecul
pass
variou
druglik
adm
filter
see
method
section
gener
curtail
databas
molecul
prefilt
databas
submit
first
stage
cascad
dock
gold
time
speed
mode
set
number
genet
oper
perform
gener
singl
dock
pose
reduc
factor
time
compar
gold
standard
mode
lead
shorter
calcul
time
ten
dock
pose
gener
everi
ligand
top
rank
pose
base
goldscor
select
comparison
across
multipl
ligand
ligand
rank
base
goldscor
top
select
second
stage
cascad
dock
use
gold
time
speed
mode
top
molecul
base
goldscor
stage
select
similar
fashion
submit
final
stage
cascad
dock
run
use
gold
standard
mode
highest
comput
complex
set
top
rank
pose
base
goldscor
rescor
use
cscore
modul
sybyl
allow
evalu
use
five
differ
score
function
fscore
gscore
pmfscore
dscore
chemscor
pose
rerank
cumul
score
obtain
sum
six
differ
score
includ
goldscor
top
molecul
select
next
stage
cluster
analysi
top
molecul
conduct
identifi
major
chemic
class
present
molecul
compris
top
rank
molecul
everi
cluster
select
visual
inspect
group
toprank
structur
divers
molecul
obtain
cluster
analysi
visual
inspect
base
abil
occupi
key
substrat
specif
site
geometr
qualiti
ligand
bind
pose
hydrophil
lipophil
mismatch
complementar
key
interact
featur
final
molecul
select
basi
visual
inspect
purchas
biolog
evalu
ident
puriti
puriti
compound
check
use
hplc
h
nmr
data
provid
vendor
conduct
biolog
doserespons
studi
larg
select
compound
labor
intens
process
involv
signific
use
valuabl
resourc
would
judici
effort
limit
evalu
candid
compound
higher
probabl
activ
low
micromolar
rang
suitabl
futur
sar
develop
biolog
evalu
experi
current
studi
therefor
devis
twostep
procedur
involv
initi
prefiltr
step
step
preliminari
screen
test
compound
conduct
singl
concentr
lm
compound
exhibit
signific
percentag
inhibit
enzym
activ
concentr
subject
detail
doserespons
studi
determin
ic
amongst
compound
evalu
tabl
show
around
inhibit
preliminari
screen
stage
compound
subject
detail
doserespons
studi
found
ic
lm
pro
biolog
evalu
select
compound
carri
newer
crystal
structur
pro
pdb
code
cocrystal
peptid
irrevers
inhibitor
publish
unlik
cocrystal
ligand
previou
structur
pdb
code
coordin
portion
inhibitor
inaccur
newer
fig
pose
valid
studi
carri
gold
use
cocrystal
peptid
ligand
bound
pro
crystal
structur
pdb
code
variat
definit
bind
site
spheric
radiu
use
caviti
detect
score
function
util
pose
select
well
dock
constraint
also
evalu
dock
carri
gold
accuraci
level
use
automat
ga
set
accuraci
level
dock
program
perform
twice
number
genet
oper
compar
standard
mode
set
automat
ga
set
allow
program
vari
total
number
ga
oper
perform
base
complex
ligand
dock
final
dock
paramet
bind
site
definit
score
function
pose
gener
select
studi
ident
use
first
phase
screen
except
addit
constraint
set
constraint
fig
incorpor
score
function
form
extra
score
term
pose
none
constraint
satisfi
consid
receiv
lower
constraint
score
compar
satisfi
constraint
constraint
set
provid
best
result
includ
three
hydrophob
constraint
correspond
hydrophob
group
occupi
specif
site
protein
hydrogen
bond
donor
interact
n
e
h
top
rank
solut
obtain
ligand
use
goldscor
function
show
heavi
atom
rmsd
fig
actual
cocrystal
pose
consid
good
ligand
size
flexibl
final
dock
protocol
pose
valid
studi
select
enrich
studi
five
score
function
cscore
well
goldscor
evalu
abil
enrich
true
activ
enrich
graph
fig
show
amongst
score
function
evalu
gscore
follow
dscore
appear
perform
better
other
databas
screen
mark
databas
screen
mark
percentag
activ
recov
gscore
dscore
databas
screen
mark
percentag
activ
recov
respect
simultan
high
rank
activ
differ
score
function
enhanc
confid
level
dock
protocol
addit
may
supplement
shortcom
individu
score
function
evalu
bind
pose
molecul
belong
specif
structur
class
case
two
better
perform
function
gscore
dscore
combin
rang
scale
format
gener
composit
gdr
score
composit
score
show
behavior
similar
gscore
dscore
recoveri
nearli
databas
screen
mark
dock
score
protocol
util
extens
phase
screen
studi
extens
phase
screen
fig
conduct
use
top
molecul
gold
time
speed
stage
first
phase
screen
curtail
number
molecul
dock
pharmacophor
prefilt
fig
gener
catalyst
use
cocrystal
pose
implement
incorpor
three
hydrophob
featur
base
hydrophob
group
one
hydrogen
bond
donor
featur
base
carbonyl
oxygen
ketoglutamin
side
chain
molecul
pass
pharmacophor
prefilt
subject
dock
use
gold
time
speed
set
top
molecul
top
rank
basi
gdr
score
select
dock
use
gold
automat
ga
set
visual
inspect
dock
pose
far
labor
intens
critic
stage
screen
studi
enhanc
percentag
dock
pose
could
visual
inspect
addit
filtrat
criterion
introduc
use
dock
pose
base
descriptor
fig
addit
filter
use
conduct
virtual
visual
inspect
top
pose
base
abil
engag
four
pharmacophor
site
critic
bind
pro
bind
pocket
includ
three
hydrophob
occup
descriptor
site
hydrogen
bond
donor
descriptor
site
interact
bind
pose
satisfi
three
descriptor
consid
pass
filtrat
criteria
molecul
emerg
filtrat
rank
base
gdr
score
visual
inspect
top
top
base
gdr
score
conduct
use
criterion
describ
previous
thu
instead
look
top
pose
rank
databas
physic
imposs
task
could
judici
reduc
relev
one
per
knowledg
bind
site
requir
final
chemic
divers
set
compound
select
biolog
evalu
compound
test
singl
concentr
lm
one
compound
tabl
show
pro
inhibit
consid
favor
carri
doserespons
studi
compound
found
ic
lm
inhibit
pro
enzym
look
back
screen
strategi
interest
note
hit
rank
lower
top
stage
iii
first
phase
virtual
screen
yet
rank
high
enough
second
phase
screen
visual
inspect
select
biolog
evalu
second
phase
molecul
rank
within
top
gdr
score
molecul
stage
ii
still
far
select
visual
inspect
combin
score
base
rank
well
dock
pose
base
filter
help
us
dig
deeper
deck
identifi
novel
hit
knowledg
base
filter
gener
use
dock
pose
base
descriptor
help
us
curtail
top
pose
molecul
stage
iii
essenc
molecul
interest
still
score
larg
number
pose
rank
higher
one
fulfil
descriptor
criteria
remov
filter
therebi
boost
posit
bring
select
group
would
put
actual
visual
inspect
first
hit
seed
molecul
use
virtual
screen
extens
phase
add
anoth
valid
check
point
screen
protocol
molecul
retriev
gdr
score
molecul
stage
iii
extens
phase
provid
evid
identif
hit
depend
primarili
filter
criteria
use
screen
process
lesser
extent
protein
structur
util
screen
process
addit
would
also
interest
know
whether
inhibitor
identifi
virtual
screen
show
propens
coval
adduct
format
enzym
structur
analys
predict
bind
pose
fig
two
hit
reveal
import
inform
bind
site
requir
enzym
case
pyrimidin
ring
quinazolin
moieti
locat
catalyt
phenyl
ring
occupi
site
undergo
hydrophob
interact
cyclohexyl
ring
extend
pocket
surrog
hydrophob
interact
exhibit
leucin
side
chain
peptid
substrat
thioacetamid
linker
occupi
critic
pocket
wherein
carbonyl
oxygen
amid
group
form
critic
hydrogen
bond
interact
termin
furan
ring
form
hydrophob
interact
aromat
oxygen
appear
act
hydrogen
bond
acceptor
backbon
nh
also
vicin
amid
side
chain
could
form
altern
hydrogen
bond
torsion
adjust
linker
activ
molecul
also
appear
occupi
site
bicycl
ring
system
occupi
site
wherein
oxygen
amid
carbonyl
first
ring
form
hydrogen
bond
phenyl
ring
bicycl
system
form
hydrophob
interact
two
phenyl
contain
side
chain
occupi
site
requir
hydrophob
interact
carbonyl
oxygen
amid
linker
close
vicin
form
hydrogen
bond
backbon
nh
pose
catalyt
cystein
block
solvent
free
substrat
process
success
structurebas
virtual
screen
carri
identifi
two
novel
nonpeptid
inhibitor
pro
enzym
activ
low
micromolar
rang
sever
procedur
modif
incorpor
comput
well
biolog
evalu
stage
screen
led
formul
accur
time
effici
econom
screen
methodolog
cascad
dock
approach
util
screen
allow
us
attain
reason
balanc
dock
accuraci
comput
time
use
knowledg
base
filter
receptor
base
pharmacophor
prefilt
dock
pose
base
descriptor
select
process
allow
us
incorpor
better
control
screen
methodolog
dock
pose
base
descriptor
also
enhanc
realm
select
dock
pose
base
visual
inspect
supplement
role
score
function
select
process
biolog
evalu
compound
carri
twostep
process
allow
us
identifi
inhibitor
low
micromolar
activ
rang
use
timeeffici
econom
experiment
setup
addit
pose
valid
enrich
studi
conduct
crystal
structur
target
enzym
help
establish
rigor
predict
dock
protocol
could
util
futur
structurebas
drug
design
effort
put
bind
pose
fig
inhibitor
identifi
screen
appear
mimic
interact
peptid
substrat
activ
site
pro
respect
bind
pose
suggest
ligand
form
critic
hydrogen
bond
hydrophob
interact
bind
site
residu
inhibitor
show
occup
pocket
pocket
occupi
molecul
occup
pocket
use
hydrophob
group
util
addit
hydrogen
bond
site
backbon
side
chain
provid
scope
structurebas
modif
strategi
enhanc
bind
affin
hit
obtain
screen
effort
would
util
conduct
substructuresimilar
base
search
well
synthet
modif
identifi
structur
analog
molecul
could
provid
enhanc
bind
site
occup
improv
interact
profil
lead
enhanc
activ
enzym
databas
prefiltr
asinex
platinum
collect
septemb
asinex
ltd
moscow
russia
carri
util
background
util
sybyl
tripo
inc
st
loui
mo
incorpor
cshell
script
raw
databas
compris
around
molecul
clear
salt
mixtur
use
dbstripsalt
util
databas
filter
use
dbslnfilter
util
basi
druglik
paramet
mol
wt
hydrogen
bond
acceptor
hydrogen
bond
donor
c
log
p
rotat
bond
aromat
ring
molecul
problemat
group
metal
noxid
aldehyd
chloramin
nitrogensulfur
mustard
isocyanid
also
remov
curtail
databas
filter
use
admeabsorbt
admesolubl
model
accelri
inc
san
diego
ca
molecul
predict
absorbt
level
good
absorbt
predict
solubl
level
lowoptim
select
next
stage
filter
databas
compris
molecul
submit
gener
concord
tripo
inc
st
loui
mo
report
activ
molecul
includ
ketoglutamin
seri
use
dock
valid
studi
sketch
sybyl
proton
state
bond
type
atom
type
molecul
assign
manual
structur
refin
use
step
conjug
gradient
rm
converg
kcalmol
use
tripo
forc
field
gasteigerhuckel
partial
charg
method
dimer
structur
pro
util
virtual
screen
run
pro
structur
use
studi
pdb
code
contain
cocrystal
ligand
coval
bound
catalyt
cystein
residu
prepar
protein
dock
coval
bond
ligand
protein
residu
delet
proton
state
tautomer
state
hydrogen
addit
protein
carri
use
pprep
schroding
llc
portland
util
cocrystal
ligand
handl
manual
manual
proton
tautomer
state
modif
certain
key
bind
site
residu
carri
residu
particip
salt
bridg
interact
therefor
model
charg
state
form
critic
hydrogen
bond
donor
interact
glutamin
residu
side
chain
oxygen
natur
substrat
model
hise
proton
state
catalyt
diad
model
neutral
state
hydrogen
proteinligand
complex
submit
restrain
molecular
mechan
refin
use
forc
field
incorpor
impref
schroding
llc
portland
protein
structur
refin
util
final
refin
structur
use
dock
calcul
dock
studi
first
phase
carri
use
gold
ccdc
cambridg
uk
bind
site
defin
use
caviti
detect
algorithm
search
around
sulfur
atom
first
phase
valid
studi
carri
use
gold
standard
mode
goldscor
function
pose
select
score
ligand
bind
pose
use
multipl
score
function
conduct
use
cscore
modul
sybyl
pose
valid
enrich
studi
extens
phase
screen
conduct
gold
use
automat
ga
accuraci
level
final
dock
protocol
extens
phase
ident
first
phase
term
bind
site
definit
score
function
pose
select
hydrophob
constraint
fig
defin
sphere
radiu
defin
around
centroid
heavi
atom
hydrophob
group
protein
hydrogen
bond
donor
constraint
fig
defin
use
n
e
h
enrich
studi
conduct
use
dataset
compris
activ
supplementari
inform
fig
dummi
inact
molecul
taken
zinc
databas
http
zincdockingorg
rang
scale
score
calcul
use
express
implement
python
script
n
rang
scale
rang
scale
score
n
score
obtain
molecul
within
dock
set
max
maximum
score
obtain
molecul
within
dock
set
min
minimum
score
obtain
molecul
within
dock
set
gdr
n
n
min
max
min
gscore
n
min
max
min
dscore
pharmacophor
prefilt
fig
gener
catalyst
accelri
inc
san
diego
ca
use
pdb
code
cocrystal
ligand
pose
hydrophob
featur
defin
sphere
toler
valu
locat
geometr
centroid
heavi
atom
relev
ligand
side
chain
hydrogen
bond
acceptor
featur
defin
use
side
chain
carbonyl
oxygen
ketoglutamin
group
molecul
enumer
conform
gener
fast
mode
fit
conform
pharmacophor
handl
use
fast
fit
method
dock
pose
base
descriptor
fig
virtual
visual
inspect
gener
use
silver
ccdc
cambridg
uk
use
pdb
code
cocrystal
ligand
protein
complex
four
descriptor
three
hydrophob
one
hydrogen
bond
defin
given
pose
could
attain
score
rang
hydrophob
descriptor
definit
similar
hydrophob
featur
pharmacophor
prefilt
consist
sphere
radiu
occup
sphere
volum
ligand
hydrophob
atom
consid
posit
occup
hydrogen
bond
donor
descriptor
defin
use
n
e
h
geometr
criteria
dha
angl
da
distanc
molecular
divers
calcul
use
dissimilar
select
modul
sybyl
method
use
prepar
assay
pro
describ
previous
bacha
et
al
briefli
plasmidencod
pro
polyhistidin
tag
express
star
escherichia
coli
compet
cell
four
cultur
grown
induc
four
pellet
approxim
g
harvest
store
purif
process
pellet
resuspend
lysi
buffer
mm
potassium
chlorid
ph
mm
sodium
chlorid
mm
potassium
chlorid
glycerol
triton
mm
imidazol
broken
french
press
lysat
centrifug
supernat
collect
load
nickel
affin
column
pharmacia
preequilibr
bind
buffer
mm
sodium
phosphat
ph
mm
sodium
chlorid
mm
imidazol
column
wash
bind
buffer
proteas
elut
bind
buffer
plu
mm
imidazol
histidin
tag
remov
thrombin
cleavag
enzym
show
puriti
assess
sdspage
purifi
proteas
concentr
store
storag
buffer
mm
sodium
phosphat
ph
mm
nacl
mm
tcep
mm
edta
glycerol
purifi
enzym
assay
use
fluorogen
peptid
dabcyltsavlqsgfredan
found
activ
condit
assay
mm
sodium
phosphat
ph
mm
nacl
mm
tcep
mm
edta
lm
fluorogen
peptid
lm
pro
k
fluorogen
peptid
determin
combin
variou
concentr
fluorogen
peptid
lm
lm
pro
determin
lm
compound
screen
inhibitori
activ
lm
follow
condit
mm
sodium
phosphat
ph
mm
nacl
mm
tcep
mm
edta
lm
fluorogen
peptid
lm
pro
increas
fluoresc
measur
min
compound
show
signific
inhibit
util
conduct
doserespons
studi
supplementari
data
associ
articl
found
onlin
version
